Description: CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Home Page: ceribell.com
360 North Pastoria Avenue
Sunnyvale,
CA
94085
United States
Phone:
800 436 0826
Officers
| Name | Title |
|---|---|
| Dr. Xingjuan Chao Ph.D. | Co-Founder, President, CEO & Director |
| Dr. Josef Parvizi M.D., Ph.D. | Co-Founder, Chief Medical Advisor & Director |
| Mr. Scott Blumberg | Chief Financial Officer |
| Dr. Raymond Woo Ph.D. | Chief Technology Officer |
| Mr. Joshua Copp | Chief Business Officer |
| Mr. Dan Rogy | Senior Vice President of Operations |
| David Foehr | Senior VP, Finance and PAO |
| Ms. Louisa Daniels J.D., M.B.A. | General Counsel |
| Mr. Sean Manni | Senior Vice President of Sales |
| Mr. Brian P. Price | Senior Vice President of Marketing |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2024-10-11 |
| Fiscal Year End: | December |
| Full Time Employees: | 229 |